14-Jan-2009 - Albany Molecular Research, Inc. (AMRI)

AMRI Names Senior Director, Analytical and Quality Services

AMRI announced that Junan Guo, Ph.D. has joined the company as senior director, analytical and quality services. Dr. Guo fills the role vacated by Dr. Steven Hagen, who was promoted to vice president of pharmaceutical development and manufacturing in September 2008.

Dr. Guo will oversee all domestic analytical chemistry, preformulation and formulation, quality assurance and regulatory affairs efforts, including support related to early stage discovery and preclinical development, as well as the manufacturing of clinical trial materials, intermediates, and commercial active pharmaceutical ingredients. This includes developing analytical methods to test the purity of clinical trial candidates and commercial products manufactured at AMRI. He will provide leadership to a team of over 100 skilled scientists and quality professionals, and work closely with customers.

Prior to joining AMRI, Dr. Guo was director, analytical development at Patheon. There, he managed a scientific staff of about 170 individuals at multiple locations responsible for supporting contract dosage form development and manufacturing services. He began his tenure at Patheon in 1999 in the role of supervisor, analytical development. Prior to Patheon, he worked at Genpharm, Inc. in Toronto, Canada in the areas of analytical R&D and technology transfer.

Dr. Guo earned a Ph.D. in physical organic chemistry from The University of Western Ontario. He also holds a master’s degree in medicinal chemistry from the Chinese Academy of Medical Sciences in Beijing, and a bachelor’s degree in chemistry from Beijing Normal University.

Facts, background information, dossiers
  • active pharmaceutic…
More about Albany Molecular Research
  • News

    AMRI to Close Holywell, U.K. API Manufacturing Facility

    AMRI announced that it has decided to close its Holywell, U.K. facility following a consultation process with employee representatives. The Holywell site provides chemical development services and small- and large scale-manufacturing services of active pharmaceutical ingredients (API) and i ... more

    AMRI Opens New Research Facility in Budapest, Hungary

    AMRI announced that it has finished the construction of a new state-of-the-art chemistry R&D facility in Budapest, Hungary. The successful completion and move into 32,300 square feet (3,000 square meters) of laboratory and administrative space marks a significant milestone in the company’s ... more

    AMRI Names New Chemistry Director at Its European Site

    AMRI has named Dr. Philip William Small as director of chemistry at its Hungarian site. In his new position, Dr. Small will assume responsibilities for all of AMRI's European chemistry related activities including custom synthesis, medicinal chemistry, analytical services, library design an ... more

  • Companies

    Albany Molecular Research, Inc. (AMRI)

    Founded in 1991 as Albany Molecular Research, Inc., AMRI provides scientific services, products and technologies focused on improving the quality of life. The company has steadily evolved, with global facilities now in the United States, Europe and Asia. Its 1,200+ employees have the expe ... more